骨诱导的HER2促进HR+/HER2-乳腺癌的二次转移
Rahat Alam1,2,3, Anna Reva1,2,3, David G Edwards4,5,6
1Icahn School of Medicine, Mount Sinai, New York, New York.
Cancer discovery
|January 21, 2025
概括
阻断人类表皮生长因子受体2 (HER2) 中介转移改善了乳腺癌患者的治疗结果. HER2被确定为HR+/HER2-乳腺癌骨转移的关键生物标志物.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症转移研究 癌症转移研究
背景情况:
- 转移仍然是癌症相关死亡的主要原因.
- 迫切需要采取阻止转移进展的策略.
- 激素受体阳性,人体表皮生长因子受体2-阴性 (HR+/HER2-) 乳腺癌约占所有乳腺癌病例的70%.
研究的目的:
- 研究HER2在调解二次转移中的作用.
- 评估阻断HER2介导转移的临床影响.
- 确定HER2作为HR+/HER2-乳腺癌骨转移的潜在生物标志物.
主要方法:
- 该研究可能涉及临床前模型和患者数据分析.
- 研究了HER2介导转移的机制.
- 与骨转移发病率和患者结局相关的HER2状态.
主要成果:
- 阻断HER2介导的二次转移被证明可以改善临床结果.
- 在研究的患者队列中,HER2被确定为骨转移的显著生物标志物.
- 这一发现对于HR+/HER2-乳腺癌患者的大小小组尤为重要.
结论:
- 针对HER2介导的转移提供了一个有前途的治疗策略.
- 在HR+/HER2-乳腺癌中,HER2作为预测骨转移风险的有价值生物标志物.
- 这些发现有助于开发更有效的乳腺癌转移治疗方法.
相关概念视频
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K


